Research graph
References from Can Moderna's mRNA cancer vaccine for cutaneous melanoma be applicable to melanomas of the eye and ocular adnexa?. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study
10.1200/jco-26-00835 · 2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2025 · External reference
Cutaneous Melanoma in Asians
10.4068/cmj.2016.52.3.185 · 2016 · External reference
10.1038/s41572-020-0158-0
10.1038/s41572-020-0158-0 · 2020 · External reference
Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors
10.1167/iovs.64.13.45 · 2023 · External reference
Correlation of Fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma
2024 · External reference
Impact of iris color on uveal melanoma-related outcomes in 7245 patients at a single ocular oncology center
2024 · External reference
Genomic and transcriptomic landscape of conjunctival melanoma
10.1371/journal.pgen.1009201 · 2020 · External reference
Uveal melanoma: Current evidence on prognosis, treatment and potential developments
2024 · External reference
An optimized 3T MRI scan protocol to assess iris melanoma with subsequent histopathological verification – A prospective study
2024 · External reference
Gain of chromosome 8q and high expression of EZH2 may predict poor prognosis in Chinese patients with uveal melanoma
2024 · External reference
Targeted therapy in ophthalmic oncology: The current status
2024 · External reference
Uveal Melanoma: Identifying Immunological and Chemotherapeutic Targets to Treat Metastases
2017 · External reference
Conjunctival melanoma in aotearoa-New Zealand: a 21-year analysis of incidence and survival
10.1097/apo.0000000000000606 · 2023 · External reference
